We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Controversies |

Using a Drug Before the Risks and Benefits Are Known From a Phase 3 Clinical Trial Thoughts on Compassion

Joan W. Miller, MD
Arch Ophthalmol. 2006;124(7):1029-1031. doi:10.1001/archopht.124.7.1029.
Text Size: A A A
Published online


Compassion is an essential component of the moral compass that informs our behavior as physicians. It is at the basis of the principle that the needs of the patient are paramount. However, there are instances in which ethical, legal, or logistical considerations may constrain physicians from acting with what they interpret as compassion. This article explores one such dilemma that sooner or later is apt to confront the clinician.

Most available drugs have been approved by phase 3 trials for some specific indication or indications. Because the risks and benefits have been identified through appropriate testing in human subjects, there is no hesitancy to use them for the appropriate indications. However, there are instances in which we find ourselves tempted to use an “approved” drug for another indication for which the risks and benefits have not been established by phase 3 trials. In addition, we may contemplate the use of drugs that are in the process of being evaluated or for which such evaluations are contemplated. We occasionally must decide whether we should enroll a patient in a clinical trial in which he or she may receive a placebo or a drug that is by definition yet to be approved. In making all of these decisions, it is important to recognize that the likely alternative—not to treat the patient with the drug in question—carries with it risks that may be more difficult to anticipate than those established in the phase 3 trial of the drug. Either course of action may also leave the physician vulnerable to allegations of medical negligence.



Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

4 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles